BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7021331)

  • 41. Pancreatic endocrine tumors.
    Heitz PU; Kasper M; Polak JM; Klöppel G
    Hum Pathol; 1982 Mar; 13(3):263-71. PubMed ID: 7076209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
    Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
    Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Endocrinologic studies of tumors of Langerhans Islands].
    Yamaguchi K; Abe K
    Nihon Rinsho; 1980; 38(1):30-8. PubMed ID: 6248656
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of naloxone and morphine on postprandial gastrointestinal hormone secretion.
    Champion MC; Sullivan SN; Bloom SR; Adrian TE; Christofides ND
    Am J Gastroenterol; 1982 Sep; 77(9):617-20. PubMed ID: 7051818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasoactive intestinal polypeptide: elevated plasma and tissue levels in the watery-diarrhea syndrome due to pancreatic and other tumors.
    Said SI
    Trans Assoc Am Physicians; 1975; 88():87-93. PubMed ID: 1224442
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma VIP in patients with watery diarrhea syndrome.
    Gardner JD
    Am J Dig Dis; 1978 Apr; 23(4):370-3. PubMed ID: 665633
    [No Abstract]   [Full Text] [Related]  

  • 47. Pancreatic-polypeptide-producing apudoma of the liver.
    Warner TF; Seo IS; Madura JA; Polak JM; Pearse AG
    Cancer; 1980 Sep; 46(5):1146-51. PubMed ID: 7194135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pancreatic-polypeptide-producing tumor of the stomach.
    Solt J; Kádas I; Polak JM; Németh A; Bloom SR; Rauth J; Horváth L
    Cancer; 1984 Sep; 54(6):1101-4. PubMed ID: 6467136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pheochromocytoma producing vasoactive intestinal peptide.
    Smith SL; Slappy AL; Fox TP; Scolapio JS
    Mayo Clin Proc; 2002 Jan; 77(1):97-100. PubMed ID: 11795252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Life threatening diarrhoea ultimately cured by surgery.
    Sjöqvist U; Permert J; Löfberg R; Larsson J; Gadaleanu V; Adrian TE
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):963-7. PubMed ID: 9872620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metastatic pancreatic polypeptide producing tumour presenting with diabetes mellitus.
    Quin JD; Marshall DA; Fisher BM; MacCuish AC
    Scott Med J; 1991 Oct; 36(5):143. PubMed ID: 1788544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic diarrhea, ganglioneuroma and vasoactive intestinal polypeptide (VIP)].
    Leupold D; Rösch U; Zöllner E; Poley JR
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):462-3. PubMed ID: 876203
    [No Abstract]   [Full Text] [Related]  

  • 53. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
    Kunert H; Kuhn FM; Schwemmle K; Ottenjann R
    Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Letter: Human pancreatic polypeptide, vasoactive intestinal polypeptide, and watery diarrhoea syndrome.
    Larsson LI
    Lancet; 1976 Jul; 2(7977):149. PubMed ID: 59216
    [No Abstract]   [Full Text] [Related]  

  • 55. Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide.
    Schebalin M; Said SI; Makhlouf GM
    Am J Physiol; 1977 Feb; 232(2):E197-200. PubMed ID: 320878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
    Wood SM; Kraenzlin ME; Adrian TE; Bloom SR
    Gut; 1985 May; 26(5):438-44. PubMed ID: 2860052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinically silent gross hypergastrinaemia from a multiple hormone-secreting pancreatic apudoma.
    Joffe SN; Elias E; Rehfeld JF; Polak JM; Bloom SR; Welbourn RB
    Br J Surg; 1978 Apr; 65(4):277-80. PubMed ID: 205304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
    Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
    Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
    Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
    Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.